𝐍𝐚𝐧𝐨𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦, 𝐛𝐫𝐢𝐝𝐠𝐢𝐧𝐠 𝐥𝐚𝐛 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭.

By distilling complex research, industry trends, and regulatory, clinical, and preclinical data: CAR-T, LNPs, RNA, delivery tech, ADCs & personalized medicine into clear, actionable insights, NanoSphere accelerates nanomedicine from bench to bedside fueling scientists, regulators, startups, and investors to act, build, and scale.

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐞𝐚𝐜𝐡 𝐠𝐞𝐭 𝐨𝐮𝐭 𝐨𝐟 𝐍𝐚𝐧𝐨𝐒𝐩𝐡𝐞𝐫𝐞?

𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜𝐬 → Visibility + Industry Context
𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 → Tech scouting + BD leads
𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐬 → Early risk signals across platforms
𝐂𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧𝐬 → Signals from preclinical/clinical studies
𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 → Emerging trends platform potential

What this looks like in practice

– 8 active collaborations across academia (2) and industry (6)
– Direct participation in the COST Action on mRNA-based therapeutics 
– 150+ curated academic posts, plus living resources
– 10,000+ niche, high-intent website views
– Global reach across 40+ centers, rooted in Switzerland 
– 37 KOL interviews published in 2025
–12-person expert team (academic, industry, clinical, regulatory, business)

Tools built by scientists:
– NanoSphere GPTs trained on our own curated datasets
– N/P ratio calculator
– Nanomedicine learner
– Conference, grant & job finder
– Continuously updated resource hub: https://www.nanosphere.ch/resources-page

NanoSphere is the go-to for anyone serious about moving nanomedicine from bench to bedside.

𝐑𝐞𝐚𝐝. 𝐅𝐨𝐥𝐥𝐨𝐰. 𝐎𝐫 𝐰𝐨𝐫𝐤 𝐰𝐢𝐭𝐡 𝐮𝐬.

NanoSphere

Org chart

Teams

Offices